Giacomo Di Nepi

Giacomo Di Nepi, Chief Executive Officer. He brings over 30 years’ experience in the industry, most recently as Executive Vice President and General Manager, Europe for InterMune Inc., where he launched Esbriet, an orphan drug, and built from scratch a USD 140 million and 200 people business – until the acquisition of InterMune by Roche for USD 8.3bn. Prior, he was in senior leadership responsibilities with Takeda and Novartis, where he was also member of the Pharma Executive Committee, and was a Partner with McKinsey&Co. He currently serves on the boards of Geneuro (GNRO.PA) and NTC, a privately held Company. Giacomo Di Nepi holds a degree in Economics from Bocconi University, Milan, Italy and an MBA from INSEAD, Fontainebleau, France.